Shares of the biotech company surged nearly 25 percent on over 1 million shares traded Monday after reporting the publication of favorable results of a preclinical study for ENMD-2076 in “triple-negative” breast cancer.
Going forward ... (see research report)
Copyright ® 2014. The Bedford Report. All Rights Reserved.